Show Menu

A fully integrated developer and manufacturer of ovine polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for October 2015

MicroPharm-PHE Ebola Partnership in the Spotlight

MicroPharm is pleased to announce that its promising ovine polyclonal antibody against Ebola, developed in collaboration with Public Health England (PHE) and the University of Oxford, has been in the spotlight as an example of good practice in knowledge exchange and commercialisation.

Read the full story

Posted on: Friday, 16th October 2015